دورية أكاديمية
Successful Treatment of Cutaneous Larva Migrans With Combined Albendazole and Ivermectin Therapy: A Report of Two Cases From Sudan.
| العنوان: | Successful Treatment of Cutaneous Larva Migrans With Combined Albendazole and Ivermectin Therapy: A Report of Two Cases From Sudan. |
|---|---|
| المؤلفون: | Shamad M; College of Medicine, University of Bahri, Khartoum, SDN.; Faculty of Medicine, Kuwait University, Kuwait City, KWT., Al-Mutairi N; Faculty of Medicine, Kuwait University, Kuwait City, KWT. |
| المصدر: | Cureus [Cureus] 2024 Jul 16; Vol. 16 (7), pp. e64665. Date of Electronic Publication: 2024 Jul 16 (Print Publication: 2024). |
| نوع المنشور: | Case Reports; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Palo Alto, CA : Cureus, Inc. |
| مستخلص: | Cutaneous larva migrans (CLM), caused by third-stage filariform larvae of cat and dog hookworms, presents as pruritic, serpiginous tracks upon skin penetration by larvae from contaminated soil. Herein, we report the successful treatment of two CLM patients using albendazole and ivermectin combination therapy. A 42-year-old man from Kordofan and a 38-year-old man from White Nile State presented with characteristic lesions on their lower extremities, resolving completely within one week post-treatment without recurrence. This report highlights the potential of combined albendazole-ivermectin therapy in managing CLM amid emerging antihelminthic resistance, suggesting that its broader application warrants further investigation. Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. (Copyright © 2024, Shamad et al.) |
| References: | Dermatology. 2002;205(2):207-9. (PMID: 12218250) J Am Acad Dermatol. 2007 Jun;56(6):1026-43. (PMID: 17382432) South Med J. 1996 Jun;89(6):609-11. (PMID: 8638201) Lancet Infect Dis. 2008 May;8(5):302-9. (PMID: 18471775) Parasitology. 2024 Mar;151(3):271-281. (PMID: 38163962) PLoS Negl Trop Dis. 2018 Apr 27;12(4):e0006458. (PMID: 29702653) Am J Trop Med Hyg. 1993 Nov;49(5):641-4. (PMID: 8250105) Lancet Infect Dis. 2019 Sep;19(9):1034. (PMID: 31478509) PLoS Pathog. 2023 Mar 2;19(3):e1011146. (PMID: 36862759) J Dermatolog Treat. 2012 Jun;23(3):189-91. (PMID: 21294643) |
| فهرسة مساهمة: | Keywords: albendazole; creeping eruption; helminthic infection; hookworm; ivermectin; larva migrans; treatment |
| تواريخ الأحداث: | Date Created: 20240718 Latest Revision: 20240719 |
| رمز التحديث: | 20240719 |
| مُعرف محوري في PubMed: | PMC11253558 |
| DOI: | 10.7759/cureus.64665 |
| PMID: | 39021742 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2168-8184 |
|---|---|
| DOI: | 10.7759/cureus.64665 |